N.J. Admin. Code § 13:35-2A.14

Current through Register Vol. 56, No. 21, November 4, 2024

Section 13:35-2A.14 - Prescriptive authorization

(a) A CNM who is licensed with the Board of Medical Examiners may apply for authorization to prescribe drugs (as used within this section, the term "drugs" shall include drugs, medicine, and devices). The CNM shall make application on forms prescribed by the Board and shall demonstrate:

1. Current registration with the Board;

2. A.C.N.M. or A.C.C. certification in good standing; and

3. Evidence of satisfactory completion of a minimum of 30 contact hours in pharmacology, which was either part of the midwifery program the CNM completed pursuant to N.J.A.C. 13:35-2A.4(a)3 or a pharmacology course offered by, or affiliated with, a college or university accredited by an accrediting association recognized by the U.S. Department of Education. The 30 contact hours shall include:

i. Instruction in fundamentals of pharmacology and therapeutics, including principles and terminology of pharmacodynamics and pharmaco-kinetics; and

ii. One contact hour on issues concerning prescription opioid drugs, including responsible prescribing practices, alternatives to opioids for managing and treating pain, and the risks and signs of opioid abuse, addiction, and diversion.

(b) If the 30 contact hours in pharmacology required pursuant to (a)3 above was included as part of the midwifery program the CNM completed pursuant to 13:35-2A.4(a)3, the CNM shall have graduated from the midwifery program within the two years immediately preceding the date on which the application for prescriptive authority is made.

(c) If the 30 contact hours in pharmacology required pursuant to (a)3 above was not part of the midwifery program the CNM completed pursuant to 13:35-2A.4(a)3, the CNM shall have completed the pharmacology course within the two years immediately preceding the date on which the application for prescriptive authority is filed.

(d) Notwithstanding (a), (b) and (c) above, a CNM who holds prescriptive authorization in another state shall be authorized to prescribe drugs in New Jersey, if the CNM submits proof to the Committee that he or she:

1. Holds current prescriptive authorization, without disciplinary restrictions, in another state; and

2. Has completed 30 contact hours in pharmacology, which meets the requirements of (a)3 above.

(e) Notwithstanding (a), (b) and (c) above, a CNM who also holds certification as an advanced practice nurse from the New Jersey Board of Nursing shall be authorized to prescribe drugs pursuant to 45:10-17 et seq., if the CNM submits proof to the Committee that he or she:

1. Holds current, unencumbered certification as an advanced practice nurse from the New Jersey Board of Nursing; and

2. Has completed 30 contact hours in pharmacology, which meets the requirements of (a)3 above.

(f) A CNM who is authorized to prescribe drugs may prescribe only those drugs which are categorized in the formulary of drugs established in the clinical guidelines.

(g) A CNM's authorization to prescribe drugs, medicine, or devices may, upon notice and an opportunity for a hearing pursuant to the Administrative Procedure Act, 52:14B-1 et seq. and 52:14F-1 et seq., be revoked or otherwise limited by the Board if the CNM:

1. Fails to maintain current licensure and registration with the Board;

2. Fails to maintain certification in good standing with the ACNM or ACC, or their successors;

3. Uses prescriptive authorization for other than therapeutic purposes; or

4. Uses prescriptive authorization to prescribe substances or devices not included in the formulary of drugs established in the CNM's clinical guidelines.

(h) Prescriptions written by a CNM shall conform to the dictates of 45:14-14 et seq. and 13:35-7.2.

(i) When prescribing controlled dangerous substances, a CNM shall comply with all of the requirements and limitations as set forth in N.J.A.C. 13:35-7.6 and 13:45H.

N.J. Admin. Code § 13:35-2A.14

Amended by 49 N.J.R. 1433(a), effective 6/5/2017

Amended by 51 N.J.R. 878(a), effective 6/3/2019